全文获取类型
收费全文 | 31535篇 |
免费 | 3012篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 319篇 |
儿科学 | 1054篇 |
妇产科学 | 607篇 |
基础医学 | 4291篇 |
口腔科学 | 637篇 |
临床医学 | 3443篇 |
内科学 | 6119篇 |
皮肤病学 | 422篇 |
神经病学 | 2902篇 |
特种医学 | 953篇 |
外国民族医学 | 3篇 |
外科学 | 4362篇 |
综合类 | 844篇 |
一般理论 | 44篇 |
预防医学 | 3121篇 |
眼科学 | 898篇 |
药学 | 2415篇 |
中国医学 | 26篇 |
肿瘤学 | 2144篇 |
出版年
2021年 | 426篇 |
2020年 | 329篇 |
2019年 | 496篇 |
2018年 | 532篇 |
2017年 | 397篇 |
2016年 | 445篇 |
2015年 | 524篇 |
2014年 | 795篇 |
2013年 | 1150篇 |
2012年 | 1632篇 |
2011年 | 1720篇 |
2010年 | 867篇 |
2009年 | 915篇 |
2008年 | 1513篇 |
2007年 | 1720篇 |
2006年 | 1618篇 |
2005年 | 1674篇 |
2004年 | 1593篇 |
2003年 | 1400篇 |
2002年 | 1362篇 |
2001年 | 858篇 |
2000年 | 840篇 |
1999年 | 825篇 |
1998年 | 432篇 |
1997年 | 312篇 |
1996年 | 336篇 |
1995年 | 304篇 |
1994年 | 271篇 |
1993年 | 257篇 |
1992年 | 597篇 |
1991年 | 571篇 |
1990年 | 560篇 |
1989年 | 540篇 |
1988年 | 506篇 |
1987年 | 495篇 |
1986年 | 515篇 |
1985年 | 461篇 |
1984年 | 378篇 |
1983年 | 296篇 |
1982年 | 281篇 |
1981年 | 223篇 |
1980年 | 203篇 |
1979年 | 313篇 |
1978年 | 227篇 |
1977年 | 181篇 |
1976年 | 197篇 |
1975年 | 185篇 |
1974年 | 210篇 |
1973年 | 250篇 |
1972年 | 189篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
1.
2.
3.
4.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
5.
A. Cattapan K. Browne D.M. Halperin A. Di Castri P. Fullsack J. Graham J.M. Langley B.A. Taylor S.A. McNeil S.A. Halperin 《Vaccine》2019,37(2):289-295
Introduction/Hypothesis
Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014–2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study.Methods
An online survey which included participants’ prior experience with clinical trials, motivations to participate (including financial incentives), and demographic information was developed to examine the motivations of healthy participants in two phase 1 clinical vaccine trials conducted at the Canadian Center for Vaccinology in Halifax, Nova Scotia. Participants were invited via email to complete the online survey. Readability and clarity were assessed through pilot testing.Results
A total of 49 (55.7%) of 88 participants of the two studies completed the survey (22 [55%] of 40 participants from the Ebola vaccine study and 27 [56.3%] of 48 from the adjuvanted influenza vaccine study). Motivations that were most frequently ranked among participants' top three in both trials were (1) wanting to contribute to the health of others, (2) wanting to participate in something important, (3) wanting to contribute to the advancement of science, and (4) wanting to receive an incentive such as money or a tablet.Conclusions/Recommendations
Although media attention and financial compensation were more often cited by Ebola vaccine trial participants as a reason to participate, both altruistic and self-interested factors were important motivations for participants in their decision to participate in a phase 1 vaccine clinical trial. 相似文献6.
7.
8.
ABSTRACT Tryptophan (Trp) is not only a nutrient enhancer but also has systemic effects. Trp metabolites signaling through the well-known aryl hydrocarbon receptor (AhR) constitute the interface of microbiome-gut-brain axis. However, the pathway through which Trp metabolites affect central nervous system (CNS) function have not been fully elucidated. AhR participates in a broad variety of physiological and pathological processes that also highly relevant to intestinal homeostasis and CNS diseases. Via the AhR-dependent mechanism, Trp metabolites connect bidirectional signaling between the gut microbiome and the brain, mediated via immune, metabolic, and neural (vagal) signaling mechanisms, with downstream effects on behavior and CNS function. These findings shed light on the complex Trp regulation of microbiome-gut-brain axis and add another facet to our understanding that dietary Trp is expected to be a promising noninvasive approach for alleviating systemic diseases. 相似文献
9.
Shannon M. Rush DPM FACFAS Lawrence A. Ford DPM FACFAS Graham A. Hamilton DPM FACFAS 《The Journal of foot and ankle surgery》2006,45(3):156-160
To evaluate morbidity associated with surgical lengthening of the gastrocnemius, medical records were reviewed retrospectively for 126 patients (mean age, 49.7 years; range, 8-78 years) who had undergone open gastrocnemius recession. Ten patients had isolated recession; 116 had gastrocnemius recession with an additional foot or ankle procedure on the ipsilateral limb. During a mean follow-up period of 19 months (range, 6-50 months), all patients were examined for any postoperative complications associated with the recession. Complications were defined as the presence of postoperative infection, wound dehiscence, nerve problems, decreased muscle strength, scar problems, or calcaneus gait (overlengthening). Uncomplicated outcome was defined as absence of all these complications and return to regular activity, both occurring during a follow-up of at least 6 months. Postsurgical complications developed in 9 (6%) of the 126 patients: 6 (4%) had scar problems, 2 (1.33%) had wound dehiscence, 2 (1.33%) had infection, 3 (2%) had nerve problems, and 1 (0.67%) developed complex regional pain syndrome. No patient complained of either a limp or gait disturbance. Neither persistent decrease in muscle strength nor calcaneus gait was seen. These data suggest that the open gastrocnemius recession procedure has low associated morbidity. 相似文献
10.
The authors present a case of rickets in an adolescent girl who presented to the emergency department with bone pain. Emergency department staff should be aware that rickets is not just a disease of early childhood. 相似文献